Did anything change? Caregivers and schizophrenia after medication changes

Area of Science:

• Psychiatry
• Sociology
• Qualitative Research

Background:

• Caregivers of individuals with schizophrenia often face blame and criticism.
• Their experiences are frequently marginalized in literature and clinical practice.
• Atypical neuroleptics represent a significant medication change in schizophrenia management.

Purpose of the Study:

• To qualitatively explore the lived experiences of relatives and partners caring for individuals with enduring schizophrenia effects.
• To critically analyze the positioning of caregivers within mental health discourse.
• To compare caregiver narratives with mental health professional literature.

Main Methods:

• Qualitative critical study utilizing in-depth interviews with caregivers.
• Foucauldian discourse analysis of caregiver interviews and mental health professional literature.
• Comparative analysis of language and power dynamics in caregiver positioning.

Main Results:

• Caregivers reported prolonged diagnostic delays and ambivalence towards medication.
• A recurring theme was the commitment to 'never giving up' on their loved ones.
• Analysis revealed similarities and differences in caregiver and professional discourse.

Conclusions:

• Caregiving for individuals with schizophrenia is inherently challenging, marked by stigma.
• Caregivers experience both personal stigma and vicarious stigma through their relatives.
• The study highlights the need for greater recognition and support for family caregivers in schizophrenia care.